Boston Scientific Predicts IVT Revenues Will Balloon Following Acquisition

Boston Scientific remains committed to ongoing merger negotiations with Medinol despite its $345 mil. cash acquisition of Interventional Technologies, which gives it access to IVT's LP coronary stent line.